Drug Trial Radar · NCT07032662
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
162
Planned (sponsor's estimate)
Start
Mar 18, 2025
Primary completion
Aug 2028
Study completion May 2030
Sponsor
- Lead sponsor
- Immunovant Sciences GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jun 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2b study to evaluate the efficacy and safety of Imeroprubart in adults with CIDP.
Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
Interventions
ImeroprubartDrug
Dose 1 subcutaneous (SC) once weekly (QW) for 24 weeks (Period 1) and 52 weeks (Period 2)
PlaceboDrug
Matching placebo SC QW for 24 weeks (Period 1)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants remaining Relapse-free by Week 24Time frame: Baseline, Week 24
Locations
143 sites in 30 countries. Site status is shown where the registry gives one.
Site Number - 1612
Tucson, Arizona · Recruiting
Site Number - 1618
Carlsbad, California · Recruiting
Site Number - 1637
Mission Hills, California · Recruiting
Site Number - 1619
Orange, California · Recruiting
Site Number - 1607
Rancho Mirage, California · Recruiting
Site Number -1608
San Francisco, California · Recruiting
Site Number - 1626
Parker, Colorado · Recruiting
Site Number - 1621
New Haven, Connecticut · Recruiting
Site Number - 1630
Washington D.C., District of Columbia · Recruiting
Site Number - 1601
Washington D.C., District of Columbia · Recruiting
Site Number - 1603
Maitland, Florida · Recruiting
Site Number - 1606
Miami, Florida · Recruiting
Site Number - 1617
Ormond Beach, Florida · Recruiting
Site Number - 1620
Port Charlotte, Florida · Recruiting
Site Number - 1633
Rockledge, Florida · Recruiting
Site Number - 1632
Chicago, Illinois · Recruiting
Site Number - 1602
Kansas City, Kansas · Recruiting
Site Number - 1611
Nicholasville, Kentucky · Recruiting
Site Number - 1623
Boston, Massachusetts · Recruiting
Site Number - 1625
Worcester, Massachusetts · Recruiting
Site Number - 1629
Detroit, Michigan · Recruiting
Site Number - 1634
Las Vegas, Nevada · Recruiting
Site Number - 1605
New York, New York · Recruiting
Site Number - 1627
New York, New York · Recruiting
Site Number - 1635
Chapel Hill, North Carolina · Not yet recruiting
Site Number - 1610
Charlotte, North Carolina · Recruiting
Site Number - 1624
Canton, Ohio · Not yet recruiting
Site Number - 1631
Yukon, Oklahoma · Withdrawn
Site Number - 1614
Portland, Oregon · Recruiting
Site Number - 1616
Philadelphia, Pennsylvania · Recruiting
Site Number - 1622
Houston, Texas · Recruiting
Site Number - 1628
San Antonio, Texas · Recruiting
Site Number - 1613
Milwaukee, Wisconsin · Recruiting
Site Number - 5002
Buenos Aires, Argentina · Not yet recruiting
Site Number - 5006
Buenos Aires, Argentina · Recruiting
Site Number - 5001
Córdoba, Argentina · Recruiting
Site Number - 5003
Córdoba, Argentina · Recruiting
Site Number - 5000
Rosario, Argentina · Recruiting
Site Number - 5005
Rosario, Santa Fe Province, Argentina · Recruiting
Site Number - 5100
Macquarie Park, Australia · Recruiting
Showing 40 of 143 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.